MNTN, Inc.
MNTNNYSEIndustrials · Services-Advertising · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | |
|---|---|---|
| Revenue | $290.1M | $225.6M |
| Operating income | $24.0M | −$1.6M |
| Net income | −$6.4M | −$32.9M |
| Total assets | $378.3M | $238.7M |
| Total liabilities | $72.6M | $177.5M |
| Equity | $305.7M | −$107.6M |
| EPS (diluted) | $-0.13 | $-2.38 |
| Shares out. | 16.4M | 13.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 8.3%
- Net margin
- −2.2%
- Return on equity
- −2.1%
- Return on assets
- −1.7%
- Return on capital (ROCE)
- 7.8%
- Liabilities / assets
- 19.2%
- Debt / equity
- 0.24×
- Book value / share
- $18.60
- Revenue growth (YoY)
- 28.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 6.38safe
- Accruals / assets
- −16.6%clean
- Beneish M-Score
- -3.15normal
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 6 good- Reported a net loss
- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 973,245 | 1.0 | -32.4% |
| Apr 30, 2026 | 1.4M | 3.4 | -16.1% |
| Apr 15, 2026 | 1.7M | 3.8 | +3.8% |
| Mar 31, 2026 | 1.7M | 2.5 | +3.2% |
| Mar 13, 2026 | 1.6M | 2.2 | +1.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2026
- Results of operationsFeb 10, 2026
- Results of operationsNov 4, 2025
- Results of operationsAug 5, 2025
- Amended charter or bylaws · Other material eventMay 23, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 12, 2026
- 10-QFORM 10-QMay 11, 2026
- SCHEDULE 13G/AMay 6, 2026
- 8-KFORM 8-KMay 5, 2026
- ARSApr 30, 2026
- DEFA14AApr 30, 2026
- DEF 14AApr 30, 2026
- 4FORM 4Apr 20, 2026
- 144Feb 19, 2026
- S-8FORM S-8Feb 19, 2026
- 10-KFORM 10-KFeb 19, 2026
- SCHEDULE 13GFeb 17, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.